2-bromo-1-(3,5-difluorophenyl)ethanone | CAS:220607-75-0

We serve 2-bromo-1-(3,5-difluorophenyl)ethanone CAS:220607-75-0 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
2-bromo-1-(3,5-difluorophenyl)ethanone

Chemical Name:2-bromo-1-(3,5-difluorophenyl)ethanone
CAS.NO:220607-75-0
Synonyms:2-bromo-1-(3,5-difluorophenyl)ethanone
2-bromo-3',5'-difluoroacetophenone
Molecular Formula:C8H5BrF2O
Molecular Weight:235.02600
 
Physical and Chemical Properties:
Density:1.648
Melting point:102.4ºC
Boiling point:245.8ºC
Index of Refraction:1.529
 
Specification:
Appearance:White to off-white solid
Assay:≥98.0%
Moisture:≤0.2%
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Organic synthesis intermediate



Contact us for information like 2-bromo-1-(3,5-difluorophenyl)ethanone chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,2-bromo-3′,5′-difluoroacetophenone physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,2-bromo-1-(3,5-difluorophenyl)ethanone Use and application,2-bromo-1-(3,5-difluorophenyl)ethanone technical grade,usp/ep/jp grade.


Related News: Especially tumor drugs with selective targeting characteristics. At present, about 80% of small drug (high-efficiency drug) APIs worldwide are patented drugs.Trimethylsilanol manufacturer Bristol-Myers Squibb (BMS) recently acquired Celgene, for example, which had the highest proportional R&D spend.2-Amino-5-Ethylphenol Hydrochloride supplier The slowdown of pesticide intermediates has dragged down the growth of industrial business. In the future, the pharmaceutical intermediate business will be the focus of the company’s development.2-Bromo-9,10-bis(2-naphthalenyl)anthracene vendor FT819 is derived from a clonal master engineered induced pluripotent stem cell (iPSC) line with complete elimination of T-cell receptor (TCR) expression and a novel 1XX CAR targeting CD19 inserted into the T-cell receptor alpha constant (TRAC) locus.It also said it would bar South Koreans from visiting China as tourists.